Mescaline (English Wikipedia)

Cochin J, Woods LA, Seevers MH (February 1951). "The absorption, distribution and urinary excretion of mescaline in the dog". The Journal of Pharmacology and Experimental Therapeutics. 101 (2): 205–209. PMID 14814616.

ballotpedia.org

"Colorado Proposition 122, Decriminalization and Regulated Access Program for Certain Psychedelic Plants and Fungi Initiative (2022)".

bitnest.ca

Trachsel D (2012). "Fluorine in psychedelic phenethylamines". Drug Testing and Analysis. 4 (7–8): 577–590. doi:10.1002/dta.413. PMID 22374819. Archived from the original on 3 June 2013.

books.google.com

Shulgin A, Shulgin A (1991). PiHKAL: A Chemical Love Story. Lafayette, CA: Transform Press. p. 703. ISBN 9780963009609.
Ikan R (1991). Natural Products: A Laboratory Guide 2nd Ed. San Diego: Academic Press, Inc. pp. 232–235. ISBN 978-0123705518.

cartoonician.com

"Ward Kimball's Final Farewell". cartoonician.com. 4 March 2016. Archived from the original on 6 March 2016. Retrieved 4 March 2016.

catbull.com

Crosby DM, McLaughlin JL (December 1973). "Cactus alkaloids. XIX. Crystallization of mescaline HCl and 3-methoxytyramine HCl from Trichocereus pachanoi" (PDF). Lloydia. 36 (4): 416–418. PMID 4773270. Retrieved 13 December 2013.

chacruna.net

Bury B (2 August 2021). "Could Synthetic Mescaline Protect Declining Peyote Populations?". Chacruna. Retrieved 2 November 2021.

desert-tropicals.com

"Cardon Grande (Echinopsis terscheckii)". Desert-tropicals.com. Archived from the original on 5 April 2015. Retrieved 14 January 2015.

doi.org

Ogunbodede O, McCombs D, Trout K, Daley P, Terry M (September 2010). "New mescaline concentrations from 14 taxa/cultivars of Echinopsis spp. (Cactaceae) ("San Pedro") and their relevance to shamanic practice". Journal of Ethnopharmacology. 131 (2). Elsevier BV: 356–362. doi:10.1016/j.jep.2010.07.021. PMID 20637277.
Klein MT, Kalam M, Trout K, Fowler N, Terry M (2015). "Mescaline Concentrations in Three Principal Tissues of Lophophora williamsii (Cactaceae): Implications for Sustainable Harvesting Practices". Haseltonia. 131 (2). Elsevier BV: 34–42. doi:10.2985/026.020.0107. S2CID 32474292.
Ogunbodede O, McCombs D, Trout K, Daley P, Terry M (September 2010). "New mescaline concentrations from 14 taxa/cultivars of Echinopsis spp. (Cactaceae) ("San Pedro") and their relevance to shamanic practice". Journal of Ethnopharmacology. 131 (2): 356–362. doi:10.1016/j.jep.2010.07.021. PMID 20637277.
Van Der Sypt F (3 April 2022). "Validation and exploratory application of a simple, rapid and economical procedure (MESQ) for the quantification of mescaline in fresh cactus tissue and aqueous cactus extracts". PhytoChem & BioSub Journal. doi:10.5281/zenodo.6409376.
El-Seedi HR, De Smet PA, Beck O, Possnert G, Bruhn JG (October 2005). "Prehistoric peyote use: alkaloid analysis and radiocarbon dating of archaeological specimens of Lophophora from Texas". Journal of Ethnopharmacology. 101 (1–3): 238–242. doi:10.1016/j.jep.2005.04.022. PMID 15990261.
Socha DM, Sykutera M, Orefici G (1 December 2022). "Use of psychoactive and stimulant plants on the south coast of Peru from the Early Intermediate to Late Intermediate Period". Journal of Archaeological Science. 148: 105688. Bibcode:2022JArSc.148j5688S. doi:10.1016/j.jas.2022.105688. ISSN 0305-4403. S2CID 252954052.
Bussmann RW, Sharon D (November 2006). "Traditional medicinal plant use in Northern Peru: tracking two thousand years of healing culture". Journal of Ethnobiology and Ethnomedicine. 2: 47. doi:10.1186/1746-4269-2-47. PMC 1637095. PMID 17090303.
Armijos C, Cota I, González S (February 2014). "Traditional medicine applied by the Saraguro yachakkuna: a preliminary approach to the use of sacred and psychoactive plant species in the southern region of Ecuador". Journal of Ethnobiology and Ethnomedicine. 10: 26. doi:10.1186/1746-4269-10-26. PMC 3975971. PMID 24565054.
Samorini G (1 June 2019). "The oldest archeological data evidencing the relationship of Homo sapiens with psychoactive plants: A worldwide overview". Journal of Psychedelic Studies. 3 (2): 63–80. doi:10.1556/2054.2019.008. S2CID 135116632.
Uthaug MV, Davis AK, Haas TF, Davis D, Dolan SB, Lancelotta R, et al. (March 2022). "The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects". Journal of Psychopharmacology. 36 (3): 309–320. doi:10.1177/02698811211013583. PMC 8902264. PMID 33949246.
Späth E (February 1919). "Über dieAnhalonium-Alkaloide I. Anhalin und Mezcalin". Monatshefte für Chemie und Verwandte Teile Anderer Wissenschaften (in German). 40 (2): 129–154. doi:10.1007/BF01524590. ISSN 0343-7329. S2CID 104408477.
Agin-Liebes G, Haas TF, Lancelotta R, Uthaug MV, Ramaekers JG, Davis AK (April 2021). "Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes". ACS Pharmacology & Translational Science. 4 (2): 543–552. doi:10.1021/acsptsci.1c00018. PMC 8033766. PMID 33860184.
Bender E (September 2022). "Finding medical value in mescaline". Nature. 609 (7929): S90–S91. Bibcode:2022Natur.609S..90B. doi:10.1038/d41586-022-02873-8. PMID 36171368. S2CID 252548055.
Kovacic P, Somanathan R (1 January 2009). "Novel, unifying mechanism for mescaline in the central nervous system: electrochemistry, catechol redox metabolite, receptor, cell signaling and structure activity relationships". Oxidative Medicine and Cellular Longevity. 2 (4): 181–190. doi:10.4161/oxim.2.4.9380. PMC 2763256. PMID 20716904.
Bohn A, Kiggen MH, Uthaug MV, van Oorsouw KI, Ramaekers JG, van Schie HT (5 December 2022). "Altered States of Consciousness During Ceremonial San Pedro Use". The International Journal for the Psychology of Religion. 33 (4): 309–331. doi:10.1080/10508619.2022.2139502. hdl:2066/285968. ISSN 1050-8619.
Kulma A, Szopa J (March 2007). "Catecholamies are active compounds in plants". Plant Science. 172 (3): 433–440. doi:10.1016/j.plantsci.2006.10.013.
Rosengarten H, Friedhoff AJ (1976). "A review of recent studies of the biosynthesis and excretion of hallucinogens formed by methylation of neurotransmitters or related substances". Schizophrenia Bulletin. 2 (1): 90–105. doi:10.1093/schbul/2.1.90. PMID 779022.
Slotta KH, Heller H (1930). "Über β-Phenyl-äthylamine, I. Mitteil.: Mezcalin und mezcalin-ähnliche Substanzen". Berichte der Deutschen Chemischen Gesellschaft (A and B Series). 63 (11): 3029–3044. doi:10.1002/cber.19300631117.
Kindler K, Peschke W (1932). "Über neue und über verbesserte Wege zum Aufbau von pharmakologisch wichtigen Aminen VI. Über Synthesen des Meskalins". Archiv der Pharmazie. 270 (7): 410–413. doi:10.1002/ardp.19322700709. S2CID 93188741.
Benington F, Morin R (1951). "An Improved Synthesis of Mescaline". Journal of the American Chemical Society. 73 (3): 1353. doi:10.1021/ja01147a505.
Hahn G, Rumpf F (1938). "Über β-[Oxy-phenyl]-äthylamine und ihre Umwandlungen, V. Mitteil.: Kondensation von Oxyphenyl-äthylaminen mit α-Ketonsäuren". Berichte der Deutschen Chemischen Gesellschaft (A and B Series). 71 (10): 2141–2153. doi:10.1002/cber.19380711022.
Toshitaka O, Hiroaka A (1992). "Synthesis of Phenethylamine Derivatives as Hallucinogen" (PDF). Japanese Journal of Toxicology and Environmental Health. 38 (6): 571–580. doi:10.1248/jhs1956.38.571. Archived (PDF) from the original on 9 October 2022. Retrieved 20 June 2014.
Ramirez F, Erne M (1950). "Über die Reduktion von β-Nitrostyrolen mit Lithiumaluminiumhydrid". Helvetica Chimica Acta. 33 (4): 912–916. doi:10.1002/hlca.19500330420.
Szyszka G, Slotta KH (1933). "Über β-Phenyl-äthylamine.III. Mitteilung: Neue Darstellung von Mescalin". Journal für Praktische Chemie. 137 (9–12): 339–350. doi:10.1002/prac.19331370907.
Burger A, Ramirez FA (1950). "The Reduction of Phenolic β-Nitrostyrenes by Lithium Aluminum Hydride". Journal of the American Chemical Society. 72 (6): 2781–2782. doi:10.1021/ja01162a521.
Hahn G, Wassmuth H (1934). "Über β-[Oxyphenyl]-äthylamine und ihre Umwandlungen, I. Mitteil.: Synthese des Mezcalins". Berichte der Deutschen Chemischen Gesellschaft (A and B Series). 67 (4): 696–708. doi:10.1002/cber.19340670430.
Makepeace T (1951). "A New Synthesis of Mescaline". Journal of the American Chemical Society. 71 (11): 5495–5496. doi:10.1021/ja01155a562.
Dornow A, Petsch G (1952). "Über die Darstellung des Oxymezcalins und Mezcalins 2. Mitteilung". Archiv der Pharmazie. 285 (7): 323–326. doi:10.1002/ardp.19522850704. S2CID 97553172.
Banholzer K, Campbell TW, Schmid H (1952). "Notiz über eine neue Synthese von Mezcalin, N-Methyl- und N-Dimethylmezcalin". Helvetica Chimica Acta. 35 (5): 1577–1581. doi:10.1002/hlca.19520350519.
Nichols DE (February 2004). "Hallucinogens". Pharmacology & Therapeutics. 101 (2): 131–181. doi:10.1016/j.pharmthera.2003.11.002. PMID 14761703.
Appel JB, Callahan PM (January 1989). "Involvement of 5-HT receptor subtypes in the discriminative stimulus properties of mescaline". European Journal of Pharmacology. 159 (1): 41–46. doi:10.1016/0014-2999(89)90041-1. PMID 2707301.
Monte AP, Waldman SR, Marona-Lewicka D, Wainscott DB, Nelson DL, Sanders-Bush E, et al. (September 1997). "Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives". Journal of Medicinal Chemistry. 40 (19): 2997–3008. CiteSeerX 10.1.1.690.9370. doi:10.1021/jm970219x. PMID 9301661.
Béïque JC, Imad M, Mladenovic L, Gingrich JA, Andrade R (June 2007). "Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex". Proceedings of the National Academy of Sciences of the United States of America. 104 (23): 9870–9875. Bibcode:2007PNAS..104.9870B. doi:10.1073/pnas.0700436104. PMC 1887564. PMID 17535909.
Rickli A, Moning OD, Hoener MC, Liechti ME (August 2016). "Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens" (PDF). European Neuropsychopharmacology. 26 (8): 1327–1337. doi:10.1016/j.euroneuro.2016.05.001. PMID 27216487. S2CID 6685927.
Trachsel D (2012). "Fluorine in psychedelic phenethylamines". Drug Testing and Analysis. 4 (7–8): 577–590. doi:10.1002/dta.413. PMID 22374819. Archived from the original on 3 June 2013.
Nichols DE (February 1986). "Studies of the relationship between molecular structure and hallucinogenic activity". Pharmacology, Biochemistry, and Behavior. 24 (2): 335–340. doi:10.1016/0091-3057(86)90362-x. PMID 3952123. S2CID 30796368.
Wu D, Otton SV, Inaba T, Kalow W, Sellers EM (June 1997). "Interactions of amphetamine analogs with human liver CYP2D6". Biochemical Pharmacology. 53 (11): 1605–1612. doi:10.1016/S0006-2952(97)00014-2. PMID 9264312.
Ley L, Holze F, Arikci D, Becker AM, Straumann I, Klaiber A, et al. (October 2023). "Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants". Neuropsychopharmacology. 48 (11): 1659–1667. doi:10.1038/s41386-023-01607-2. PMC 10517157. PMID 37231080.
Papaseit E, Farré M, Pérez-Mañá C, Torrens M, Ventura M, Pujadas M, et al. (2018). "Acute Pharmacological Effects of 2C-B in Humans: An Observational Study". Frontiers in Pharmacology. 9: 206. doi:10.3389/fphar.2018.00206. PMC 5859368. PMID 29593537.

erowid.org

"#96 M – Mescaline (3,4,5-Trimethoxyphenethylamine)". PIHKAL. Erowid.org. Retrieved 7 September 2011.
"Arthur Heffter". Character Vaults. Erowid.org. Retrieved 9 January 2013.
Amos D (1964). "Preparation of Mescaline from Eucalypt Lignin". Australian Journal of Pharmacy. 49: 529.
"Neuropharmacology of Hallucinogens". Erowid.org. 27 March 2009. Retrieved 7 September 2011.
Shulgin A. "#157 TMA - 3,4,5-TRIMETHOXYAMPHETAMINE". PiHKAL: A Chemical Love Story. Erowid.org. Retrieved 9 January 2013.
Smith MV. "Psychedelics and Society". Erowid.org. Retrieved 6 April 2012.
"2007 U.K. Trichocereus Cacti Legal Case Regina v. Saul Sette". Erowid.org. June 2007. Retrieved 6 April 2012.

garant.ru

base.garant.ru

"Постановление Правительства РФ от 30.06.1998 N 681 "Об утверждении перечня наркотических средств, психотропных веществ и их прекурсоров, подлежащих контролю в Российской Федерации" (с изменениями и дополнениями) - ГАРАНТ". base.garant.ru.

ghostarchive.org

Toshitaka O, Hiroaka A (1992). "Synthesis of Phenethylamine Derivatives as Hallucinogen" (PDF). Japanese Journal of Toxicology and Environmental Health. 38 (6): 571–580. doi:10.1248/jhs1956.38.571. Archived (PDF) from the original on 9 October 2022. Retrieved 20 June 2014.
"Alexander Shulgin: why I discover psychedelic substances". Luc Sala interview. Mexico. 1996. Archived from the original on 11 December 2021.

go.com

abcnews.go.com

"Could LSD treat alcoholism?". abcnews.go.com. 9 March 2012. Retrieved 5 October 2012.

handle.net

hdl.handle.net

Bohn A, Kiggen MH, Uthaug MV, van Oorsouw KI, Ramaekers JG, van Schie HT (5 December 2022). "Altered States of Consciousness During Ceremonial San Pedro Use". The International Journal for the Psychology of Religion. 33 (4): 309–331. doi:10.1080/10508619.2022.2139502. hdl:2066/285968. ISSN 1050-8619.

harvard.edu

ui.adsabs.harvard.edu

Socha DM, Sykutera M, Orefici G (1 December 2022). "Use of psychoactive and stimulant plants on the south coast of Peru from the Early Intermediate to Late Intermediate Period". Journal of Archaeological Science. 148: 105688. Bibcode:2022JArSc.148j5688S. doi:10.1016/j.jas.2022.105688. ISSN 0305-4403. S2CID 252954052.
Bender E (September 2022). "Finding medical value in mescaline". Nature. 609 (7929): S90–S91. Bibcode:2022Natur.609S..90B. doi:10.1038/d41586-022-02873-8. PMID 36171368. S2CID 252548055.
Béïque JC, Imad M, Mladenovic L, Gingrich JA, Andrade R (June 2007). "Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex". Proceedings of the National Academy of Sciences of the United States of America. 104 (23): 9870–9875. Bibcode:2007PNAS..104.9870B. doi:10.1073/pnas.0700436104. PMC 1887564. PMID 17535909.

huffingtonpost.com

Boardman M (10 July 2013). "Michael Cera Took Drugs On-Camera". Huffington Post.

iceers.org

ICEERS (20 September 2019). "San Pedro: Basic Info". ICEERS. Retrieved 6 June 2024.

in.gov.br

Anvisa (24 July 2023). "RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 25 July 2023). Archived from the original on 27 August 2023. Retrieved 27 August 2023.

incb.org

"List of psychotropic substances under international control" (PDF). International Narcotics Control Board. Archived from the original (PDF) on 5 December 2005. Retrieved 27 January 2008.

justice.gc.ca

laws-lois.justice.gc.ca

"Justice Laws Search". laws-lois.justice.gc.ca. Retrieved 5 October 2012.

legislation.gov.au

Poisons Standard February 2020. comlaw.gov.au

lucid.news

Carpenter DE (8 July 2021). "Mescaline is Resurgent (Yet Again) As a Potential Medicine". Lucid News. Retrieved 28 February 2022.

mescaline.com

"Mescaline : D M Turner". www.mescaline.com.

netfirms.com

entheogen.netfirms.com

Forbidden Fruit Archives Archived 2005-11-28 at the Wayback Machine

newyorker.com

"The Father of Flower Power". The New Yorker. 10 August 1968. Retrieved 3 April 2022.

nih.gov

pubmed.ncbi.nlm.nih.gov

Ogunbodede O, McCombs D, Trout K, Daley P, Terry M (September 2010). "New mescaline concentrations from 14 taxa/cultivars of Echinopsis spp. (Cactaceae) ("San Pedro") and their relevance to shamanic practice". Journal of Ethnopharmacology. 131 (2). Elsevier BV: 356–362. doi:10.1016/j.jep.2010.07.021. PMID 20637277.
Ogunbodede O, McCombs D, Trout K, Daley P, Terry M (September 2010). "New mescaline concentrations from 14 taxa/cultivars of Echinopsis spp. (Cactaceae) ("San Pedro") and their relevance to shamanic practice". Journal of Ethnopharmacology. 131 (2): 356–362. doi:10.1016/j.jep.2010.07.021. PMID 20637277.
Crosby DM, McLaughlin JL (December 1973). "Cactus alkaloids. XIX. Crystallization of mescaline HCl and 3-methoxytyramine HCl from Trichocereus pachanoi" (PDF). Lloydia. 36 (4): 416–418. PMID 4773270. Retrieved 13 December 2013.
El-Seedi HR, De Smet PA, Beck O, Possnert G, Bruhn JG (October 2005). "Prehistoric peyote use: alkaloid analysis and radiocarbon dating of archaeological specimens of Lophophora from Texas". Journal of Ethnopharmacology. 101 (1–3): 238–242. doi:10.1016/j.jep.2005.04.022. PMID 15990261.
Bussmann RW, Sharon D (November 2006). "Traditional medicinal plant use in Northern Peru: tracking two thousand years of healing culture". Journal of Ethnobiology and Ethnomedicine. 2: 47. doi:10.1186/1746-4269-2-47. PMC 1637095. PMID 17090303.
Armijos C, Cota I, González S (February 2014). "Traditional medicine applied by the Saraguro yachakkuna: a preliminary approach to the use of sacred and psychoactive plant species in the southern region of Ecuador". Journal of Ethnobiology and Ethnomedicine. 10: 26. doi:10.1186/1746-4269-10-26. PMC 3975971. PMID 24565054.
Uthaug MV, Davis AK, Haas TF, Davis D, Dolan SB, Lancelotta R, et al. (March 2022). "The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects". Journal of Psychopharmacology. 36 (3): 309–320. doi:10.1177/02698811211013583. PMC 8902264. PMID 33949246.
Agin-Liebes G, Haas TF, Lancelotta R, Uthaug MV, Ramaekers JG, Davis AK (April 2021). "Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes". ACS Pharmacology & Translational Science. 4 (2): 543–552. doi:10.1021/acsptsci.1c00018. PMC 8033766. PMID 33860184.
Bender E (September 2022). "Finding medical value in mescaline". Nature. 609 (7929): S90–S91. Bibcode:2022Natur.609S..90B. doi:10.1038/d41586-022-02873-8. PMID 36171368. S2CID 252548055.
Kovacic P, Somanathan R (1 January 2009). "Novel, unifying mechanism for mescaline in the central nervous system: electrochemistry, catechol redox metabolite, receptor, cell signaling and structure activity relationships". Oxidative Medicine and Cellular Longevity. 2 (4): 181–190. doi:10.4161/oxim.2.4.9380. PMC 2763256. PMID 20716904.
Rosengarten H, Friedhoff AJ (1976). "A review of recent studies of the biosynthesis and excretion of hallucinogens formed by methylation of neurotransmitters or related substances". Schizophrenia Bulletin. 2 (1): 90–105. doi:10.1093/schbul/2.1.90. PMID 779022.
Nichols DE (February 2004). "Hallucinogens". Pharmacology & Therapeutics. 101 (2): 131–181. doi:10.1016/j.pharmthera.2003.11.002. PMID 14761703.
Appel JB, Callahan PM (January 1989). "Involvement of 5-HT receptor subtypes in the discriminative stimulus properties of mescaline". European Journal of Pharmacology. 159 (1): 41–46. doi:10.1016/0014-2999(89)90041-1. PMID 2707301.
Monte AP, Waldman SR, Marona-Lewicka D, Wainscott DB, Nelson DL, Sanders-Bush E, et al. (September 1997). "Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives". Journal of Medicinal Chemistry. 40 (19): 2997–3008. CiteSeerX 10.1.1.690.9370. doi:10.1021/jm970219x. PMID 9301661.
Béïque JC, Imad M, Mladenovic L, Gingrich JA, Andrade R (June 2007). "Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex". Proceedings of the National Academy of Sciences of the United States of America. 104 (23): 9870–9875. Bibcode:2007PNAS..104.9870B. doi:10.1073/pnas.0700436104. PMC 1887564. PMID 17535909.
Rickli A, Moning OD, Hoener MC, Liechti ME (August 2016). "Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens" (PDF). European Neuropsychopharmacology. 26 (8): 1327–1337. doi:10.1016/j.euroneuro.2016.05.001. PMID 27216487. S2CID 6685927.
Trachsel D (2012). "Fluorine in psychedelic phenethylamines". Drug Testing and Analysis. 4 (7–8): 577–590. doi:10.1002/dta.413. PMID 22374819. Archived from the original on 3 June 2013.
Nichols DE (February 1986). "Studies of the relationship between molecular structure and hallucinogenic activity". Pharmacology, Biochemistry, and Behavior. 24 (2): 335–340. doi:10.1016/0091-3057(86)90362-x. PMID 3952123. S2CID 30796368.
Wu D, Otton SV, Inaba T, Kalow W, Sellers EM (June 1997). "Interactions of amphetamine analogs with human liver CYP2D6". Biochemical Pharmacology. 53 (11): 1605–1612. doi:10.1016/S0006-2952(97)00014-2. PMID 9264312.
Cochin J, Woods LA, Seevers MH (February 1951). "The absorption, distribution and urinary excretion of mescaline in the dog". The Journal of Pharmacology and Experimental Therapeutics. 101 (2): 205–209. PMID 14814616.
Ley L, Holze F, Arikci D, Becker AM, Straumann I, Klaiber A, et al. (October 2023). "Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants". Neuropsychopharmacology. 48 (11): 1659–1667. doi:10.1038/s41386-023-01607-2. PMC 10517157. PMID 37231080.
Papaseit E, Farré M, Pérez-Mañá C, Torrens M, Ventura M, Pujadas M, et al. (2018). "Acute Pharmacological Effects of 2C-B in Humans: An Observational Study". Frontiers in Pharmacology. 9: 206. doi:10.3389/fphar.2018.00206. PMC 5859368. PMID 29593537.

ncbi.nlm.nih.gov

Bussmann RW, Sharon D (November 2006). "Traditional medicinal plant use in Northern Peru: tracking two thousand years of healing culture". Journal of Ethnobiology and Ethnomedicine. 2: 47. doi:10.1186/1746-4269-2-47. PMC 1637095. PMID 17090303.
Armijos C, Cota I, González S (February 2014). "Traditional medicine applied by the Saraguro yachakkuna: a preliminary approach to the use of sacred and psychoactive plant species in the southern region of Ecuador". Journal of Ethnobiology and Ethnomedicine. 10: 26. doi:10.1186/1746-4269-10-26. PMC 3975971. PMID 24565054.
Uthaug MV, Davis AK, Haas TF, Davis D, Dolan SB, Lancelotta R, et al. (March 2022). "The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects". Journal of Psychopharmacology. 36 (3): 309–320. doi:10.1177/02698811211013583. PMC 8902264. PMID 33949246.
Agin-Liebes G, Haas TF, Lancelotta R, Uthaug MV, Ramaekers JG, Davis AK (April 2021). "Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes". ACS Pharmacology & Translational Science. 4 (2): 543–552. doi:10.1021/acsptsci.1c00018. PMC 8033766. PMID 33860184.
Kovacic P, Somanathan R (1 January 2009). "Novel, unifying mechanism for mescaline in the central nervous system: electrochemistry, catechol redox metabolite, receptor, cell signaling and structure activity relationships". Oxidative Medicine and Cellular Longevity. 2 (4): 181–190. doi:10.4161/oxim.2.4.9380. PMC 2763256. PMID 20716904.
Béïque JC, Imad M, Mladenovic L, Gingrich JA, Andrade R (June 2007). "Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex". Proceedings of the National Academy of Sciences of the United States of America. 104 (23): 9870–9875. Bibcode:2007PNAS..104.9870B. doi:10.1073/pnas.0700436104. PMC 1887564. PMID 17535909.
Ley L, Holze F, Arikci D, Becker AM, Straumann I, Klaiber A, et al. (October 2023). "Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants". Neuropsychopharmacology. 48 (11): 1659–1667. doi:10.1038/s41386-023-01607-2. PMC 10517157. PMID 37231080.
Papaseit E, Farré M, Pérez-Mañá C, Torrens M, Ventura M, Pujadas M, et al. (2018). "Acute Pharmacological Effects of 2C-B in Humans: An Observational Study". Frontiers in Pharmacology. 9: 206. doi:10.3389/fphar.2018.00206. PMC 5859368. PMID 29593537.

nootropicsfrontline.com

Toshitaka O, Hiroaka A (1992). "Synthesis of Phenethylamine Derivatives as Hallucinogen" (PDF). Japanese Journal of Toxicology and Environmental Health. 38 (6): 571–580. doi:10.1248/jhs1956.38.571. Archived (PDF) from the original on 9 October 2022. Retrieved 20 June 2014.

philipkdickfans.com

"FLOW MY TEARS". www.philipkdickfans.com. Retrieved 4 May 2018.

psu.edu

citeseerx.ist.psu.edu

Monte AP, Waldman SR, Marona-Lewicka D, Wainscott DB, Nelson DL, Sanders-Bush E, et al. (September 1997). "Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives". Journal of Medicinal Chemistry. 40 (19): 2997–3008. CiteSeerX 10.1.1.690.9370. doi:10.1021/jm970219x. PMID 9301661.

psychedelicreview.com

"Mescaline". Psychedelic Science Review. 2 December 2019. Retrieved 30 October 2023.

psychologytoday.com

Dixit J (23 June 2008). "George Carlin's Last Interview". Psychology Today.

rollingstone.com

Doyle P (20 May 2019). "Patti Smith Channels French Poet Antonin Artaud on Peyote". Rolling Stone. Retrieved 3 April 2022.
Greene A (1989). "Dazed and Confused: 10 Classic Drugged-Out Shows". Rolling Stone. Santana at Woodstock, 1969 - Mescaline

sacredcacti.com

"Acacia species with data conflicts". sacredcacti.com. 16 January 2015. Retrieved 13 March 2021.

semanticscholar.org

api.semanticscholar.org

Klein MT, Kalam M, Trout K, Fowler N, Terry M (2015). "Mescaline Concentrations in Three Principal Tissues of Lophophora williamsii (Cactaceae): Implications for Sustainable Harvesting Practices". Haseltonia. 131 (2). Elsevier BV: 34–42. doi:10.2985/026.020.0107. S2CID 32474292.
Socha DM, Sykutera M, Orefici G (1 December 2022). "Use of psychoactive and stimulant plants on the south coast of Peru from the Early Intermediate to Late Intermediate Period". Journal of Archaeological Science. 148: 105688. Bibcode:2022JArSc.148j5688S. doi:10.1016/j.jas.2022.105688. ISSN 0305-4403. S2CID 252954052.
Samorini G (1 June 2019). "The oldest archeological data evidencing the relationship of Homo sapiens with psychoactive plants: A worldwide overview". Journal of Psychedelic Studies. 3 (2): 63–80. doi:10.1556/2054.2019.008. S2CID 135116632.
Späth E (February 1919). "Über dieAnhalonium-Alkaloide I. Anhalin und Mezcalin". Monatshefte für Chemie und Verwandte Teile Anderer Wissenschaften (in German). 40 (2): 129–154. doi:10.1007/BF01524590. ISSN 0343-7329. S2CID 104408477.
Bender E (September 2022). "Finding medical value in mescaline". Nature. 609 (7929): S90–S91. Bibcode:2022Natur.609S..90B. doi:10.1038/d41586-022-02873-8. PMID 36171368. S2CID 252548055.
Kindler K, Peschke W (1932). "Über neue und über verbesserte Wege zum Aufbau von pharmakologisch wichtigen Aminen VI. Über Synthesen des Meskalins". Archiv der Pharmazie. 270 (7): 410–413. doi:10.1002/ardp.19322700709. S2CID 93188741.
Dornow A, Petsch G (1952). "Über die Darstellung des Oxymezcalins und Mezcalins 2. Mitteilung". Archiv der Pharmazie. 285 (7): 323–326. doi:10.1002/ardp.19522850704. S2CID 97553172.
Rickli A, Moning OD, Hoener MC, Liechti ME (August 2016). "Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens" (PDF). European Neuropsychopharmacology. 26 (8): 1327–1337. doi:10.1016/j.euroneuro.2016.05.001. PMID 27216487. S2CID 6685927.
Nichols DE (February 1986). "Studies of the relationship between molecular structure and hallucinogenic activity". Pharmacology, Biochemistry, and Behavior. 24 (2): 335–340. doi:10.1016/0091-3057(86)90362-x. PMID 3952123. S2CID 30796368.

sotcaa.net

"Panorama: The Mescaline Experiment". February 2005. Archived from the original on 26 July 2012.

tamu.edu

uvalde.tamu.edu

Forbes TD, Clement BA. "Chemistry of Acacia's from South Texas" (PDF). Texas A&M Agricultural Research & Extension Center at Uvalde. Archived from the original (PDF) on 15 May 2011.

themescalinegarden.com

"Mescaline in Trichocereus". The Mescaline Garden. Retrieved 9 August 2024.

thenook.org

"Partial List of Alkaloids in Trichocereus Cacti". Thennok.org. Archived from the original on 11 February 2009. Retrieved 22 December 2017.

unibas.ch

edoc.unibas.ch

Rickli A, Moning OD, Hoener MC, Liechti ME (August 2016). "Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens" (PDF). European Neuropsychopharmacology. 26 (8): 1327–1337. doi:10.1016/j.euroneuro.2016.05.001. PMID 27216487. S2CID 6685927.

usdoj.gov

United States Department of Justice. "Drug Scheduling". Archived from the original on 20 October 2008. Retrieved 2 November 2007.

utcourts.gov

"State v. Mooney". utcourts.gov. Retrieved 5 October 2012.

web.archive.org

Anvisa (24 July 2023). "RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 25 July 2023). Archived from the original on 27 August 2023. Retrieved 27 August 2023.
Forbes TD, Clement BA. "Chemistry of Acacia's from South Texas" (PDF). Texas A&M Agricultural Research & Extension Center at Uvalde. Archived from the original (PDF) on 15 May 2011.
"Cardon Grande (Echinopsis terscheckii)". Desert-tropicals.com. Archived from the original on 5 April 2015. Retrieved 14 January 2015.
"Partial List of Alkaloids in Trichocereus Cacti". Thennok.org. Archived from the original on 11 February 2009. Retrieved 22 December 2017.
Forbidden Fruit Archives Archived 2005-11-28 at the Wayback Machine
"Panorama: The Mescaline Experiment". February 2005. Archived from the original on 26 July 2012.
Trachsel D (2012). "Fluorine in psychedelic phenethylamines". Drug Testing and Analysis. 4 (7–8): 577–590. doi:10.1002/dta.413. PMID 22374819. Archived from the original on 3 June 2013.
United States Department of Justice. "Drug Scheduling". Archived from the original on 20 October 2008. Retrieved 2 November 2007.
"List of psychotropic substances under international control" (PDF). International Narcotics Control Board. Archived from the original (PDF) on 5 December 2005. Retrieved 27 January 2008.
"Ward Kimball's Final Farewell". cartoonician.com. 4 March 2016. Archived from the original on 6 March 2016. Retrieved 4 March 2016.

wikisource.org

pl.wikisource.org

Witkiewicz SI, Biczysko S (1932). Nikotyna, alkohol, kokaina, peyotl, morfina, eter+ appendix. Warsaw: Drukarnia Towarzystwa Polskiej Macierzy Szkolnej.

worldcat.org

search.worldcat.org

Socha DM, Sykutera M, Orefici G (1 December 2022). "Use of psychoactive and stimulant plants on the south coast of Peru from the Early Intermediate to Late Intermediate Period". Journal of Archaeological Science. 148: 105688. Bibcode:2022JArSc.148j5688S. doi:10.1016/j.jas.2022.105688. ISSN 0305-4403. S2CID 252954052.
Späth E (February 1919). "Über dieAnhalonium-Alkaloide I. Anhalin und Mezcalin". Monatshefte für Chemie und Verwandte Teile Anderer Wissenschaften (in German). 40 (2): 129–154. doi:10.1007/BF01524590. ISSN 0343-7329. S2CID 104408477.
Bohn A, Kiggen MH, Uthaug MV, van Oorsouw KI, Ramaekers JG, van Schie HT (5 December 2022). "Altered States of Consciousness During Ceremonial San Pedro Use". The International Journal for the Psychology of Religion. 33 (4): 309–331. doi:10.1080/10508619.2022.2139502. hdl:2066/285968. ISSN 1050-8619.

youtube.com

"Alexander Shulgin: why I discover psychedelic substances". Luc Sala interview. Mexico. 1996. Archived from the original on 11 December 2021.

zenodo.org

Van Der Sypt F (3 April 2022). "Validation and exploratory application of a simple, rapid and economical procedure (MESQ) for the quantification of mescaline in fresh cactus tissue and aqueous cactus extracts". PhytoChem & BioSub Journal. doi:10.5281/zenodo.6409376.